A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

CHD Exome+ Consortium, CARDIOGRAM Exome Consortium, GERAD-EC Consortium, Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE)

Research output: Contribution to journalArticle

49 Scopus citations

Fingerprint Dive into the research topics of 'A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease'. Together they form a unique fingerprint.

Medicine & Life Sciences